» Authors » Michael C Thigpen

Michael C Thigpen

Explore the profile of Michael C Thigpen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 2375
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Weir B, Wirtz A, Chemnasiri T, Baral S, Decker M, Dun C, et al.
Lancet Reg Health Southeast Asia . 2023 Aug; 15:100217. PMID: 37614346
Background: Daily oral pre-exposure prophylaxis (PrEP) is effective in preventing HIV infection, but no study has evaluated combination prevention interventions with PrEP for transgender women (TGW) and men who have...
2.
Thigpen M, Sarath S, Soeung S, Vichit O, Kitsutani P, Sandhu H, et al.
BMC Public Health . 2022 Dec; 22(1):2244. PMID: 36456999
A mass Japanese encephalitis (JE) immunization campaign for children aged 9 months through 12 years was conducted in 2013 in Battambang province, western Cambodia. Vaccinators working at almost 2,000 immunization...
3.
Hills S, Soeung S, Sarath S, Morn C, Dara C, Fischer M, et al.
PLoS One . 2022 Jun; 17(6):e0269480. PMID: 35679297
Introduction: Japanese encephalitis (JE) virus is the most common cause of vaccine-preventable encephalitis in Asia. The SA14-14-2 JE vaccine manufactured by Chengdu Institute of Biological Products has been shown to...
4.
Weir B, Dun C, Wirtz A, Mon S, Qaragholi N, Chemnasiri T, et al.
Ann Epidemiol . 2022 Apr; 72:1-8. PMID: 35405344
Purpose: To examine how recent sex work is identified and the HIV risk factors and service needs among Thai cisgender men who have sex with men (MSM) and transgender women...
5.
Pattanasin S, Cadwell B, Smith D, Sukwicha W, Mock P, Wimonsate W, et al.
Int J STD AIDS . 2020 May; 31(7):637-641. PMID: 32448077
In Thailand, pre-exposure prophylaxis (PrEP) is recommended for human immunodeficiency virus (HIV) prevention among at-risk men who have sex with men (MSM). We modeled the impact of PrEP and condom...
6.
Wirtz A, Weir B, Mon S, Sirivongrangson P, Chemnasiri T, Dunne E, et al.
JMIR Res Protoc . 2020 Feb; 9(1):e15354. PMID: 32012113
Background: Pre-exposure prophylaxis (PrEP) is highly effective in the prevention of HIV acquisition, particularly for men who have sex with men (MSM). Questions remain on the benefits of PrEP and...
7.
Godfrey C, Thigpen M, Crawford K, Jean-Phillippe P, Pillay D, Persaud D, et al.
J Infect Dis . 2017 Oct; 216(suppl_9):S798-S800. PMID: 28973412
No abstract available.
8.
9.
Cutland C, Schrag S, Thigpen M, Velaphi S, Wadula J, Adrian P, et al.
Emerg Infect Dis . 2015 Mar; 21(4):638-45. PMID: 25812061
Although group B Streptococcus (GBS) is a leading cause of severe invasive disease in young infants worldwide, epidemiologic data and knowledge about risk factors for the disease are lacking from...
10.
Kasonde M, Niska R, Rose C, Henderson F, Segolodi T, Turner K, et al.
PLoS One . 2014 Mar; 9(3):e90111. PMID: 24625530
Background: Tenofovir-emtricitabine (TDF-FTC) pre-exposure prophylaxis (PrEP) has been found to be effective for prevention of HIV infection in several clinical trials. Two studies of TDF PrEP among men who have...